Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Probiotic-Derived Ecto-5'-Nucleotidase Produces Anti-Inflammatory Adenosine Metabolites in Treg-Deficient Scurfy Mice.
Liu Y, Armbrister SA, Okeugo B, Mills TW, Daniel RC, Oh JH, van Pijkeren JP, Park ES, Saleh ZM, Lahiri S, Roos S, Rhoads J. Liu Y, et al. Among authors: van pijkeren jp. Probiotics Antimicrob Proteins. 2023 Aug;15(4):1001-1013. doi: 10.1007/s12602-023-10089-z. Epub 2023 May 13. Probiotics Antimicrob Proteins. 2023. PMID: 37178405 Free PMC article.
Genetically Engineered Probiotic Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer.
Hamade DF, Epperly MW, Fisher R, Hou W, Shields D, van Pijkeren JP, Leibowitz BJ, Coffman LG, Wang H, Huq MS, Huang Z, Rogers CJ, Vlad AM, Greenberger JS, Mukherjee A. Hamade DF, et al. Among authors: van pijkeren jp. Cancers (Basel). 2024 Jan 23;16(3):474. doi: 10.3390/cancers16030474. Cancers (Basel). 2024. PMID: 38339228 Free PMC article.
Release of Interferon-β (IFN-β) from Probiotic Limosilactobacillus reuteri-IFN-β (LR-IFN-β) Mitigates Gastrointestinal Acute Radiation Syndrome (GI-ARS) following Whole Abdominal Irradiation.
Hamade DF, Epperly MW, Fisher R, Hou W, Shields D, van Pijkeren JP, Mukherjee A, Yu J, Leibowitz BJ, Vlad AM, Coffman L, Wang H, Huq MS, Huang Z, Rogers CJ, Greenberger JS. Hamade DF, et al. Among authors: van pijkeren jp. Cancers (Basel). 2023 Mar 8;15(6):1670. doi: 10.3390/cancers15061670. Cancers (Basel). 2023. PMID: 36980556 Free PMC article.
Development of a Limosilactobacillus reuteri therapeutic delivery platform with reduced colonization potential.
Alexander LM, Khalid S, Gallego-Lopez GM, Astmann TJ, Oh J-H, Heggen M, Huss P, Fisher R, Mukherjee A, Raman S, Choi IY, Smith MN, Rogers CJ, Epperly MW, Knoll LJ, Greenberger JS, van Pijkeren J-P. Alexander LM, et al. Appl Environ Microbiol. 2024 Nov 20;90(11):e0031224. doi: 10.1128/aem.00312-24. Epub 2024 Oct 31. Appl Environ Microbiol. 2024. PMID: 39480094 Free PMC article.
Allosteric Regulation of Pyruvate Kinase Enables Efficient and Robust Gluconeogenesis by Preventing Metabolic Conflicts and Carbon Overflow.
She F, Anderson BW, Khana DB, Zhang S, Steinchen W, Fung DK, Lucas LN, Lesser NG, Stevenson DM, Astmann TJ, Bange G, van Pijkeren JP, Amador-Noguez D, Wang JD. She F, et al. Among authors: van pijkeren jp. bioRxiv [Preprint]. 2024 Aug 15:2024.08.15.607825. doi: 10.1101/2024.08.15.607825. bioRxiv. 2024. PMID: 39211278 Free PMC article. Preprint.
Modes of therapeutic delivery in synthetic microbiology.
Alexander LM, van Pijkeren JP. Alexander LM, et al. Among authors: van pijkeren jp. Trends Microbiol. 2023 Feb;31(2):197-211. doi: 10.1016/j.tim.2022.09.003. Epub 2022 Oct 8. Trends Microbiol. 2023. PMID: 36220750 Free PMC article. Review.
57 results